X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (217) 217
index medicus (167) 167
oncology (167) 167
female (117) 117
male (114) 114
middle aged (111) 111
aged (101) 101
cancer (98) 98
colorectal cancer (97) 97
adult (83) 83
chemotherapy (81) 81
colorectal neoplasms - pathology (68) 68
colorectal neoplasms - drug therapy (65) 65
metastasis (63) 63
treatment outcome (58) 58
antineoplastic combined chemotherapy protocols - therapeutic use (55) 55
bevacizumab (42) 42
disease-free survival (41) 41
oxaliplatin (41) 41
prognosis (41) 41
survival (39) 39
care and treatment (37) 37
neoplasm staging (36) 36
biochemistry (34) 34
culture media (34) 34
beer (33) 33
chemistry (33) 33
clinical trials (33) 33
compositions thereof (33) 33
enzymology (33) 33
metallurgy (33) 33
microbiology (33) 33
microorganisms or enzymes (33) 33
mutation or genetic engineering (33) 33
patients (33) 33
propagating, preserving or maintaining microorganisms (33) 33
research (33) 33
spirits (33) 33
vinegar (33) 33
wine (33) 33
capecitabine (32) 32
colorectal neoplasms - genetics (32) 32
metastases (32) 32
neoplasm metastasis (32) 32
dendritic cells - immunology (31) 31
enzymes (30) 30
surgery (30) 30
aged, 80 and over (29) 29
antineoplastic agents - therapeutic use (29) 29
colorectal carcinoma (29) 29
hematology, oncology and palliative medicine (29) 29
colorectal neoplasms - mortality (28) 28
fluorouracil - administration & dosage (28) 28
tumors (28) 28
analysis (27) 27
cancer therapies (26) 26
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (26) 26
immunotherapy (26) 26
combination chemotherapy (25) 25
therapy (25) 25
vaccination (25) 25
melanoma (24) 24
melanoma - immunology (24) 24
organoplatinum compounds - administration & dosage (24) 24
fluorouracil (23) 23
camptothecin - analogs & derivatives (22) 22
deoxycytidine - analogs & derivatives (22) 22
drug administration schedule (22) 22
liver neoplasms - secondary (22) 22
randomized controlled trials as topic (22) 22
dendritic cells (21) 21
general tagging of cross-sectional technologies spanning over several sections of the ipc (21) 21
general tagging of new technological developments (21) 21
medicine & public health (21) 21
reduction of greenhouse gas [ghg] emissions, related to energygeneration, transmission or distribution (21) 21
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (21) 21
technologies or applications for mitigation or adaptation againstclimate change (21) 21
bleaching leather or furs (20) 20
cetuximab (20) 20
dry-cleaning, washing or bleaching fibres, filaments, threads,yarns, fabrics, feathers or made-up fibrous goods (20) 20
flexible materials not otherwise provided for (20) 20
fluorouracil - analogs & derivatives (20) 20
immunology (20) 20
laundering (20) 20
mutation (20) 20
paper (20) 20
phase-iii (20) 20
survival analysis (20) 20
textiles (20) 20
treatment of textiles or the like (20) 20
irinotecan (19) 19
studies (19) 19
1st-line treatment (18) 18
abridged index medicus (18) 18
deoxycytidine - administration & dosage (18) 18
expression (18) 18
patient outcomes (18) 18
retrospective studies (18) 18
health aspects (17) 17
medicine, general & internal (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. CT089 - CT089
Journal Article
BMC cancer, ISSN 1471-2407, 04/2019, Volume 19, Issue 1, p. 390
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 3522 - 3522
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 6612 - 6612
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 9, pp. 1090 - 1098
Journal Article
Strahlentherapie und Onkologie, ISSN 0179-7158, 08/2017, Volume 193, Issue 8, pp. 630 - 638
textabstractBackground: The Dutch Pancreatic Cancer Group initiated the national, multicentre, controlled PREOPANC trial, randomising between preoperative... 
Planning techniques | Oncology | Klinische Studie | Radiotherapy | Klinisches Protokolle | Medicine & Public Health | Computed tomography | Computertomographie | Clinical protocols | Clinical trial | Fiducial markers | Planungstechnik | Fiducial-Marker | CLINICAL TARGET VOLUME | GUIDELINES | RADIATION-THERAPY | VARIABILITY | DELINEATION | CT | ONCOLOGY | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Reproducibility of Results | Guideline Adherence - statistics & numerical data | Chemoradiotherapy, Adjuvant - standards | Radiotherapy, Intensity-Modulated - statistics & numerical data | Pancreatectomy - standards | Guideline Adherence - utilization | Humans | Pancreatic Neoplasms - surgery | Radiotherapy Planning, Computer-Assisted - statistics & numerical data | Pancreatic Neoplasms - radiotherapy | Male | Treatment Outcome | Preoperative Care - standards | Tumor Burden | Quality Assurance, Health Care - methods | Radiotherapy Planning, Computer-Assisted - standards | Radiotherapy, Intensity-Modulated - standards | Netherlands | Sensitivity and Specificity | Adult | Chemoradiotherapy, Adjuvant - statistics & numerical data | Female | Preoperative Care - statistics & numerical data | Quality assurance | Spinal cord | Rope | Pancreatic cancer | Quality | Delineation | Organs | Radiation therapy | Cancer therapies | Patients | Cancer | Original
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9980, pp. 1843 - 1852
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 5, pp. 616 - 622
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2009, Volume 360, Issue 6, pp. 563 - 572
Capecitabine, oxaliplatin, and bevacizumab are standard treatment for metastatic colorectal cancer. This trial tested whether adding cetuximab to this... 
CAPECITABINE | GROWTH-FACTOR RECEPTOR | MEDICINE, GENERAL & INTERNAL | PLUS OXALIPLATIN | FINAL REPORT | PHASE-III | COMBINATION CHEMOTHERAPY | IRINOTECAN | RANDOMIZED CONTROLLED-TRIAL | 1ST-LINE THERAPY | FLUOROURACIL | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Capecitabine | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Antibodies, Monoclonal, Humanized | Organoplatinum Compounds - administration & dosage | Receptor, Epidermal Growth Factor - metabolism | Fluorouracil - administration & dosage | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Treatment Failure | Aged, 80 and over | Adult | Female | Cetuximab | Receptor, Epidermal Growth Factor - immunology | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Disease-Free Survival | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quality of Life | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Mutation | Colorectal Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Care and treatment | Chemotherapy | Usage | Health aspects | Colorectal cancer | Cancer | Clinical trials | Cancer therapies | Medical treatment | Committees | Index Medicus | Abridged Index Medicus
Journal Article